Evidence map›Paper›PMID 33051927›Full record

ReviewRespirology (Carlton, Vic.)2020

Respiratory surveillance for coal mine dust and artificial stone exposed workers in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand.

Jennifer L Perret, Susan Miles, Fraser Brims, Katrina Newbigin, Maggie Davidson, Hubertus Jersmann, Adrienne Edwards, Graeme Zosky, Anthony Frankel, Anthony R Johnson and 7 more

Open access · hybridAbstract readReviewConsensus Statement
In one paragraph

Review in Respirology (Carlton, Vic.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Occupational exposure to silica dust in France: an ongoing concern.Scandinavian journal of work, environment & health · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 15 institutions in 3 countries.

Jennifer L PerretAllergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0001-7034-0615
Susan MilesDepartment of Medicine, Calvary Mater Newcastle, Newcastle, NSW, Australia.
Fraser BrimsCurtin Medical School, Curtin University, Perth, WA, Australia.ORCID 0000-0002-6725-7535
Katrina NewbiginWesley Dust Disease Research Centre, Brisbane, QLD, Australia.
Maggie DavidsonHealth and Management School of Science, Western Sydney University, Sydney, NSW, Australia.
Hubertus JersmannDepartment of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, SA, Australia.
Adrienne EdwardsChristchurch Public Hospital, Canterbury District Health Board, Christchurch, New Zealand.
Graeme ZoskyMenzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia.ORCID 0000-0001-9039-0302
Anthony FrankelBankstown Hospital, South Western Sydney Local Heath District, Sydney, NSW, Australia.
Anthony R JohnsonDepartment of Thoracic Medicine, Liverpool Hospital, Sydney, NSW, Australia.
Ryan HoySchool of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
David W ReidQIMR-Berghofer Institute of Medical Research, Brisbane, QLD, Australia.
A William MuskDepartment of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Michael J AbramsonSchool of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Bob EdwardsWesley Dust Disease Research Centre, Brisbane, QLD, Australia.
Robert CohenSchool of Public Health, University of Illinois, Chicago, IL, USA.
Deborah H YatesDepartment of Thoracic Medicine, St Vincent's Hospital, Sydney, NSW, Australia.ORCID 0000-0001-6419-6856
Monash University · AUWesley Hospital · AUBankstown Lidcombe Hospital · AUCalvary Mater Newcastle Hospital · AUCanterbury District Health Board · NZCurtin University · AUIllinois Department of Public Health · USLiverpool Hospital · AUQIMR Berghofer Medical Research Institute · AURoyal Adelaide Hospital · AUThe University of Melbourne · AUThe University of Sydney · AUThe University of Western Australia · AUUniversity of Tasmania · AUWestern Sydney University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coal mine lung dust disease (CMDLD) and artificial stone (AS) silicosis are preventable diseases which have occurred in serious outbreaks in Australia recently. This has prompted a TSANZ review of Australia's approach to respiratory periodic health surveillance. While regulating respirable dust exposure remains the foundation of primary and secondary prevention, identification of workers with early disease assists with control of further exposure, and with the aims of preserving lung function and decreasing respiratory morbidity in those affected. Prompt detection of an abnormality also allows for ongoing respiratory specialist clinical management. This review outlines a medical framework for improvements in respiratory surveillance to detect CMDLD and AS silicosis in Australia. This includes appropriate referral, improved data collection and interpretation, enhanced surveillance, the establishment of a nationwide Occupational Lung Disease Registry and an independent advisory group. These measures are designed to improve health outcomes for workers in the coal mining, AS and other dust-exposed and mining industries.

Indexed as

AnthracosisOccupational DiseasesOccupational ExposureSilicosisAustraliaCoalDustHumansManufactured MaterialsNew ZealandOccupational HealthSilicon DioxideCoalDustSilicon Dioxidecoal mine dust lung diseasepneumoconiosispreventionrespiratory surveillancesilicosis

Identifiers

PMID33051927
PMCPMC7702073
OpenAlexW3092234790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.